GE Healthcare receives CE Mark for new digital pathology scanner

GE Healthcare has announced that its Omnyx Integrated Digital Pathology (IDP) solution, with its new VL120 high volume scanner, has been approved for sale in Europe.

The system – developed by Omnyx, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center – has been granted CE Mark status for primary diagnosis in the EU under the In Vitro Diagnostic Devices Directive.

Its new scanner offers intuitive workflow benefits that enable histology labs to manage high case volumes with continuous loading capability, adapting to labs' slide production schedule.

Adding this capability to the platform means the Omnyx IDP solution can broaden patient access to collaborative and subspecialty pathology services. Launched in 2013, the offering has already been adopted by customers in Switzerland, Spain and the UK.

Mamar Gelaye, chief executive officer of Omnyx, said: "Traditionally, pathologists examine tissue slides under a microscope. Slides have to be transported to pathologists, or pathologists have to travel to other laboratories, creating delays in diagnosis and risk of slides being damaged or lost."

GE Healthcare also announced this week that it has received US regulatory approval for its new Vivid T8 cardiovascular ultrasound device.